1Yang JH, Gwon HC, Cho SJ, et al. Comparison of coronary artery bypass gaffing with drug-eluting stent implantation for the treatment of muhivessel coronary artery disease. Ann Thorae Surg, 2008,85:65-70.
2Park DW, Yun SC, Lee SW, et al. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of muhivessel coronary artery disease. Circulation, 2008, 117: 2079 -2086.
3Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in muhivessel eoronary disease. N Engl J Med, 2008,358:331-341.
4Harjai K J, Grines CL. Management of multivessel coronary disease : let us not shortchange drug-eluting stents. J Interv Cardiol, 2008,21:213-217.
5Ong AT, van der Giessen WJ. Drug-eluting stents for interventional revascularization of coronary multivessel disease. J Interv Cardiol, 2005,18:447-453.
6Kelbaek H, Thuesen L, Helqvist S, et al. The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial. J Am Coil Cardiol, 2006,47:449-455.
7Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med, 2007,356:989-997.
8Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med, 2007,356 : 1030-1039.
9Coy JJ, Stauffer JC, Siegenthaler M, et al. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology : the TAXi trial. J Am Coil Cardiol, 2005,45:308-311.
10Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med, 2005,353:653-662.
2Ribichini F, Taggart D. Implications of new ESC/EACTS guidelines on myocardial revascularization for patients with multivessel coronary artery disease[J]. EurJ Cardio?tho rae Surg,2011 ,39(5) :619-622.
3Braunwald E,Antman EM,Beasley rw.? al. ACC/AHA 2002 guideline update for the management of patients with unstable anginaand non-S'T-segment elevation myo?cardial infarction summary article: are port of the Ameri?can College of Cardiology/ American Heart Association task force on practice guidelines[J].J ACC, 2002,40 (7) : 1366.
4Park DW, Kim YH, et al. Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients withmultivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data[n. Circ Cardiovasc Interv,2012,5(4) :467-475.
5Chang TI, Shilane D, Kazi DS, et al. Multivessel coronary artery bypass grafting versus percutaneous coronary in?tervention in ESRD[J].J Am Soc Nephrol,2012,23(l2): 2042-2049.
6Gao F, Zhou YJ, Shen H, et al. Meta-analysis of percuta?neous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/ or multivessel coronary artery disease[J]. Acta Diabetol, 2012,21:l.
7Vasaiwala S, Williams DO. Revascularization for left main and multivessel coronary artery disease in the drug-elu?ting stent era: integration of recent drug-eluting stent tri?als[J]. Curr Cardiol Rep,2012,14(4) :468-476.
8Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multi vessel revascularization in patients with diabetes[J]. N EnglJ Med,2012,367(25) :2375-2384.
9Flather M,RheeJW,et al. The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among pa?tients with multivessel coronary disease: a collaborative a?nalysis of individual patient data from 10 randomized tri?als[J].J Am Coli Cardiol,2012 ,60(21) :2150-2157.
10Cuculi F, Banning AP, et al. Outcomes in patients under?going multi vessel percutaneous coronary intervention u?sing sirolimus-eluting stents . a report from the e-SELECT registry[J]. Euro Intervention, 2011 ,7(8): 962-968.
